| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3907061 | Urology | 2006 | 5 Pages |
Abstract
Although clusterin immunoreactivity showed only a trend towards an independent prognostic relevance in this study, we conclude that it may be used, in addition to conventional and other immunohistochemical prognosticators, as a supplementary tool to provide more prognostic information in patients undergoing cystectomy for muscle-invasive bladder cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Stefan Krüger, Anne Mahnken, Ingo Kausch, Alfred C. Feller,